-
2
-
-
0038690527
-
Malignant thymoma: current status of classification and multimodality treatment
-
Schmidt-Wolf I.G., Rockstroh J.K., Schüller H., Himer A., Grohe C., Müller-Hermelink H.K., and Huhn D. Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol 82 (2003) 69-76
-
(2003)
Ann Hematol
, vol.82
, pp. 69-76
-
-
Schmidt-Wolf, I.G.1
Rockstroh, J.K.2
Schüller, H.3
Himer, A.4
Grohe, C.5
Müller-Hermelink, H.K.6
Huhn, D.7
-
3
-
-
2342510977
-
Tumour recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis
-
Ströbel P., Bauer A., Puppe B., Kraushaar T., Krein A., Toyka K., Gold R., Semik M., Kiefer R., Nix W., Schalke B., Müller-Hermelink H.K., and Marx A. Tumour recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 22 (2004) 1501-1509
-
(2004)
J Clin Oncol
, vol.22
, pp. 1501-1509
-
-
Ströbel, P.1
Bauer, A.2
Puppe, B.3
Kraushaar, T.4
Krein, A.5
Toyka, K.6
Gold, R.7
Semik, M.8
Kiefer, R.9
Nix, W.10
Schalke, B.11
Müller-Hermelink, H.K.12
Marx, A.13
-
4
-
-
25444476048
-
Thymoma and Thymic carcinoma: an update of the WHO classification 2004
-
Ströbel P., Marx A., Zettl A., and Müller-Hermelink H.K. Thymoma and Thymic carcinoma: an update of the WHO classification 2004. Surg Today 35 (2005) 805-811
-
(2005)
Surg Today
, vol.35
, pp. 805-811
-
-
Ströbel, P.1
Marx, A.2
Zettl, A.3
Müller-Hermelink, H.K.4
-
5
-
-
1342332358
-
Octreotide alone or with prednisolone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial
-
Loehrer Sr. P.J., Wang W., Johnson D.H., Aisner S.C., and Ettinger D.S. Octreotide alone or with prednisolone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol 22 (2004) 293-299
-
(2004)
J Clin Oncol
, vol.22
, pp. 293-299
-
-
Loehrer Sr., P.J.1
Wang, W.2
Johnson, D.H.3
Aisner, S.C.4
Ettinger, D.S.5
-
6
-
-
0018192408
-
Regression of malignant thymoma with metastases after treatment with adrenocortical steroids
-
Almog C., Pik A., Weisberg D., and Herczeg E. Regression of malignant thymoma with metastases after treatment with adrenocortical steroids. Isr J Med Sci 14 4 (1978) 476-480
-
(1978)
Isr J Med Sci
, vol.14
, Issue.4
, pp. 476-480
-
-
Almog, C.1
Pik, A.2
Weisberg, D.3
Herczeg, E.4
-
8
-
-
0035042371
-
Regression of invasive thymoma following corticosteroid therapy
-
Termeer A., Visser F.J., and Mravunac M. Regression of invasive thymoma following corticosteroid therapy. Neth J Med 58 (2001) 181-184
-
(2001)
Neth J Med
, vol.58
, pp. 181-184
-
-
Termeer, A.1
Visser, F.J.2
Mravunac, M.3
-
9
-
-
33646378691
-
Preoperative steroid pulse therapy for invasive thymoma
-
Kobayashi Y., Fujii Y., Yano M., Sasaki H., Yukiue H., Haneda H., Suzuki E., Endo K., and Kawano O. Preoperative steroid pulse therapy for invasive thymoma. Cancer 106 9 (2006) 1901-1907
-
(2006)
Cancer
, vol.106
, Issue.9
, pp. 1901-1907
-
-
Kobayashi, Y.1
Fujii, Y.2
Yano, M.3
Sasaki, H.4
Yukiue, H.5
Haneda, H.6
Suzuki, E.7
Endo, K.8
Kawano, O.9
-
10
-
-
0028059964
-
Mechanism of apoptosis: integration of genetic, biochemical and cellular indicators
-
Stewart B.W. Mechanism of apoptosis: integration of genetic, biochemical and cellular indicators. J Nat J Cancer Inst 86 (1994) 1286-1296
-
(1994)
J Nat J Cancer Inst
, vol.86
, pp. 1286-1296
-
-
Stewart, B.W.1
|